Titre : Protéines mitochondriales

Protéines mitochondriales : Questions médicales fréquentes

Termes MeSH sélectionnés :

Time and Motion Studies

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une dysfonction mitochondriale ?

Un diagnostic peut inclure des tests génétiques, des biopsies musculaires et des analyses biochimiques.
Dysfonction mitochondriale Biopsie musculaire
#2

Quels tests sanguins sont utilisés pour évaluer les protéines mitochondriales ?

Des tests de lactate, pyruvate et des enzymes spécifiques peuvent être effectués.
Lactate Enzymes
#3

Quels symptômes indiquent une maladie mitochondriale ?

Fatigue, faiblesse musculaire, troubles neurologiques et problèmes cardiaques peuvent indiquer une maladie.
Fatigue Maladies mitochondriales
#4

Les tests génétiques sont-ils fiables pour les maladies mitochondriales ?

Oui, les tests génétiques peuvent identifier des mutations spécifiques liées aux maladies mitochondriales.
Tests génétiques Mutations
#5

Quel rôle joue l'imagerie dans le diagnostic mitochondrial ?

L'imagerie par résonance magnétique (IRM) peut aider à visualiser des anomalies cérébrales.
Imagerie par résonance magnétique Anomalies cérébrales

Symptômes 5

#1

Quels sont les symptômes courants des maladies mitochondriales ?

Les symptômes incluent fatigue, douleurs musculaires, troubles de la vision et épilepsie.
Fatigue Épilepsie
#2

Les troubles cognitifs sont-ils liés aux protéines mitochondriales ?

Oui, des troubles cognitifs peuvent survenir en raison de dysfonctionnements mitochondriaux.
Troubles cognitifs Dysfonction mitochondriale
#3

Comment la myopathie mitochondriale se manifeste-t-elle ?

Elle se manifeste par une faiblesse musculaire, des crampes et une intolérance à l'exercice.
Myopathie mitochondriale Faiblesse musculaire
#4

Les troubles cardiaques sont-ils fréquents dans les maladies mitochondriales ?

Oui, des cardiomyopathies peuvent se développer en raison de dysfonctionnements mitochondriaux.
Cardiomyopathies Dysfonctionnements mitochondriaux
#5

Les symptômes varient-ils selon l'âge d'apparition ?

Oui, les symptômes peuvent varier considérablement selon l'âge d'apparition de la maladie.
Âge d'apparition Variabilité des symptômes

Prévention 5

#1

Peut-on prévenir les maladies mitochondriales ?

Certaines maladies génétiques ne peuvent pas être prévenues, mais un mode de vie sain aide.
Prévention Mode de vie sain
#2

L'exercice physique peut-il réduire les risques ?

Oui, l'exercice régulier peut améliorer la santé mitochondriale et réduire les risques.
Exercice physique Santé mitochondriale
#3

Les antioxydants jouent-ils un rôle préventif ?

Oui, les antioxydants peuvent protéger les mitochondries des dommages oxydatifs.
Antioxydants Dommages oxydatifs
#4

Une alimentation équilibrée est-elle importante ?

Oui, une alimentation riche en nutriments soutient la santé mitochondriale.
Alimentation équilibrée Nutriments
#5

Les dépistages précoces sont-ils recommandés ?

Oui, le dépistage précoce peut aider à identifier les risques et à intervenir rapidement.
Dépistage précoce Intervention rapide

Traitements 5

#1

Quels traitements sont disponibles pour les maladies mitochondriales ?

Les traitements incluent des suppléments, des thérapies symptomatiques et des approches nutritionnelles.
Suppléments Thérapies symptomatiques
#2

Les coenzymes Q10 sont-elles bénéfiques ?

Oui, le coenzyme Q10 peut améliorer la fonction mitochondriale et réduire les symptômes.
Coenzyme Q10 Fonction mitochondriale
#3

La thérapie génique est-elle une option pour ces maladies ?

La thérapie génique est en recherche, mais elle pourrait offrir des solutions futures.
Thérapie génique Recherche
#4

Les régimes alimentaires peuvent-ils aider ?

Oui, des régimes spécifiques peuvent soutenir la fonction mitochondriale et améliorer les symptômes.
Régimes alimentaires Fonction mitochondriale
#5

Les traitements varient-ils selon le type de maladie mitochondriale ?

Oui, les traitements doivent être adaptés au type spécifique de maladie mitochondriale.
Types de maladies mitochondriales Adaptation des traitements

Complications 5

#1

Quelles complications peuvent survenir avec les maladies mitochondriales ?

Les complications incluent des troubles neurologiques, cardiaques et endocriniens.
Complications Troubles neurologiques
#2

Les maladies mitochondriales peuvent-elles affecter la fertilité ?

Oui, certaines maladies mitochondriales peuvent entraîner des problèmes de fertilité.
Fertilité Maladies mitochondriales
#3

Les complications peuvent-elles être gérées ?

Certaines complications peuvent être gérées avec des traitements symptomatiques appropriés.
Gestion des complications Traitements symptomatiques
#4

Les maladies mitochondriales augmentent-elles le risque de cancer ?

Certaines études suggèrent un lien entre dysfonction mitochondriale et risque accru de cancer.
Risque de cancer Dysfonction mitochondriale
#5

Les complications cardiovasculaires sont-elles fréquentes ?

Oui, les maladies mitochondriales peuvent entraîner des cardiomyopathies et d'autres complications.
Complications cardiovasculaires Cardiomyopathies

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les maladies mitochondriales ?

Les facteurs incluent des antécédents familiaux, des mutations génétiques et des expositions environnementales.
Antécédents familiaux Mutations génétiques
#2

L'âge est-il un facteur de risque ?

Oui, certaines maladies mitochondriales se manifestent plus fréquemment avec l'âge.
Âge Maladies mitochondriales
#3

Les facteurs environnementaux influencent-ils les maladies mitochondriales ?

Oui, l'exposition à des toxines peut augmenter le risque de dysfonction mitochondriale.
Facteurs environnementaux Toxines
#4

Le stress oxydatif est-il un facteur de risque ?

Oui, le stress oxydatif peut endommager les mitochondries et contribuer à des maladies.
Stress oxydatif Dommages mitochondriaux
#5

Les habitudes alimentaires peuvent-elles influencer le risque ?

Oui, une alimentation pauvre en nutriments peut augmenter le risque de dysfonction mitochondriale.
Habitudes alimentaires Dysfonction mitochondriale
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines mitochondriales : Questions médicales les plus fréquentes", "headline": "Protéines mitochondriales : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines mitochondriales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-12", "dateModified": "2025-04-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines mitochondriales" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines", "url": "https://questionsmedicales.fr/mesh/D011506", "about": { "@type": "MedicalCondition", "name": "Protéines", "code": { "@type": "MedicalCode", "code": "D011506", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Aldehyde dehydrogenase, mitochondrial", "alternateName": "Aldehyde Dehydrogenase, Mitochondrial", "url": "https://questionsmedicales.fr/mesh/D000071396", "about": { "@type": "MedicalCondition", "name": "Aldehyde dehydrogenase, mitochondrial", "code": { "@type": "MedicalCode", "code": "D000071396", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.093" } } }, { "@type": "MedicalWebPage", "name": "Mitochondrial creatine kinase", "alternateName": "Creatine Kinase, Mitochondrial Form", "url": "https://questionsmedicales.fr/mesh/D052281", "about": { "@type": "MedicalCondition", "name": "Mitochondrial creatine kinase", "code": { "@type": "MedicalCode", "code": "D052281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.186" } } }, { "@type": "MedicalWebPage", "name": "DNA Polymerase gamma", "alternateName": "DNA Polymerase gamma", "url": "https://questionsmedicales.fr/mesh/D000074002", "about": { "@type": "MedicalCondition", "name": "DNA Polymerase gamma", "code": { "@type": "MedicalCode", "code": "D000074002", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.280" } } }, { "@type": "MedicalWebPage", "name": "Ferrochelatase", "alternateName": "Ferrochelatase", "url": "https://questionsmedicales.fr/mesh/D005294", "about": { "@type": "MedicalCondition", "name": "Ferrochelatase", "code": { "@type": "MedicalCode", "code": "D005294", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.562" } } }, { "@type": "MedicalWebPage", "name": "Protéines de transport de la membrane mitochondriale", "alternateName": "Mitochondrial Membrane Transport Proteins", "url": "https://questionsmedicales.fr/mesh/D033681", "about": { "@type": "MedicalCondition", "name": "Protéines de transport de la membrane mitochondriale", "code": { "@type": "MedicalCode", "code": "D033681", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mitochondrial ADP, ATP Translocases", "alternateName": "Mitochondrial ADP, ATP Translocases", "url": "https://questionsmedicales.fr/mesh/D000226", "about": { "@type": "MedicalCondition", "name": "Mitochondrial ADP, ATP Translocases", "code": { "@type": "MedicalCode", "code": "D000226", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Translocateur-1 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 1", "url": "https://questionsmedicales.fr/mesh/D033741", "about": { "@type": "MedicalCondition", "name": "Translocateur-1 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033741", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.100" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-2 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 2", "url": "https://questionsmedicales.fr/mesh/D033742", "about": { "@type": "MedicalCondition", "name": "Translocateur-2 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033742", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.200" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-3 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 3", "url": "https://questionsmedicales.fr/mesh/D033781", "about": { "@type": "MedicalCondition", "name": "Translocateur-3 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033781", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.300" } } } ] }, { "@type": "MedicalWebPage", "name": "Translocateur-1 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 1", "url": "https://questionsmedicales.fr/mesh/D033741", "about": { "@type": "MedicalCondition", "name": "Translocateur-1 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033741", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.100" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-2 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 2", "url": "https://questionsmedicales.fr/mesh/D033742", "about": { "@type": "MedicalCondition", "name": "Translocateur-2 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033742", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.200" } } }, { "@type": "MedicalWebPage", "name": "Translocateur-3 de nucléotides adényliques", "alternateName": "Adenine Nucleotide Translocator 3", "url": "https://questionsmedicales.fr/mesh/D033781", "about": { "@type": "MedicalCondition", "name": "Translocateur-3 de nucléotides adényliques", "code": { "@type": "MedicalCode", "code": "D033781", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.500.300" } } }, { "@type": "MedicalWebPage", "name": "Pore de transition de perméabilité mitochondriale", "alternateName": "Mitochondrial Permeability Transition Pore", "url": "https://questionsmedicales.fr/mesh/D000083162", "about": { "@type": "MedicalCondition", "name": "Pore de transition de perméabilité mitochondriale", "code": { "@type": "MedicalCode", "code": "D000083162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.563" } } }, { "@type": "MedicalWebPage", "name": "Protéines du complexe d'import des protéines précurseurs mitochondriales", "alternateName": "Mitochondrial Precursor Protein Import Complex Proteins", "url": "https://questionsmedicales.fr/mesh/D000090622", "about": { "@type": "MedicalCondition", "name": "Protéines du complexe d'import des protéines précurseurs mitochondriales", "code": { "@type": "MedicalCode", "code": "D000090622", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.594" } } }, { "@type": "MedicalWebPage", "name": "Mitochondrial Proton-Translocating ATPases", "alternateName": "Mitochondrial Proton-Translocating ATPases", "url": "https://questionsmedicales.fr/mesh/D025261", "about": { "@type": "MedicalCondition", "name": "Mitochondrial Proton-Translocating ATPases", "code": { "@type": "MedicalCode", "code": "D025261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.625" } } }, { "@type": "MedicalWebPage", "name": "Protéines de découplage mitochondrial", "alternateName": "Mitochondrial Uncoupling Proteins", "url": "https://questionsmedicales.fr/mesh/D000071245", "about": { "@type": "MedicalCondition", "name": "Protéines de découplage mitochondrial", "code": { "@type": "MedicalCode", "code": "D000071245", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protéine-1 de découplage", "alternateName": "Uncoupling Protein 1", "url": "https://questionsmedicales.fr/mesh/D000071256", "about": { "@type": "MedicalCondition", "name": "Protéine-1 de découplage", "code": { "@type": "MedicalCode", "code": "D000071256", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.500" } } }, { "@type": "MedicalWebPage", "name": "Protéine-2 de découplage", "alternateName": "Uncoupling Protein 2", "url": "https://questionsmedicales.fr/mesh/D000071246", "about": { "@type": "MedicalCondition", "name": "Protéine-2 de découplage", "code": { "@type": "MedicalCode", "code": "D000071246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.750" } } }, { "@type": "MedicalWebPage", "name": "Protéine-3 de découplage", "alternateName": "Uncoupling Protein 3", "url": "https://questionsmedicales.fr/mesh/D000071247", "about": { "@type": "MedicalCondition", "name": "Protéine-3 de découplage", "code": { "@type": "MedicalCode", "code": "D000071247", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Protéine-1 de découplage", "alternateName": "Uncoupling Protein 1", "url": "https://questionsmedicales.fr/mesh/D000071256", "about": { "@type": "MedicalCondition", "name": "Protéine-1 de découplage", "code": { "@type": "MedicalCode", "code": "D000071256", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.500" } } }, { "@type": "MedicalWebPage", "name": "Protéine-2 de découplage", "alternateName": "Uncoupling Protein 2", "url": "https://questionsmedicales.fr/mesh/D000071246", "about": { "@type": "MedicalCondition", "name": "Protéine-2 de découplage", "code": { "@type": "MedicalCode", "code": "D000071246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.750" } } }, { "@type": "MedicalWebPage", "name": "Protéine-3 de découplage", "alternateName": "Uncoupling Protein 3", "url": "https://questionsmedicales.fr/mesh/D000071247", "about": { "@type": "MedicalCondition", "name": "Protéine-3 de découplage", "code": { "@type": "MedicalCode", "code": "D000071247", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.688.875" } } }, { "@type": "MedicalWebPage", "name": "Canal anionique-1 voltage-dépendant", "alternateName": "Voltage-Dependent Anion Channel 1", "url": "https://questionsmedicales.fr/mesh/D050995", "about": { "@type": "MedicalCondition", "name": "Canal anionique-1 voltage-dépendant", "code": { "@type": "MedicalCode", "code": "D050995", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.750" } } }, { "@type": "MedicalWebPage", "name": "Canal anionique-2 voltage-dépendant", "alternateName": "Voltage-Dependent Anion Channel 2", "url": "https://questionsmedicales.fr/mesh/D050996", "about": { "@type": "MedicalCondition", "name": "Canal anionique-2 voltage-dépendant", "code": { "@type": "MedicalCode", "code": "D050996", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.750.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Protéine trifonctionnelle mitochondriale", "alternateName": "Mitochondrial Trifunctional Protein", "url": "https://questionsmedicales.fr/mesh/D063991", "about": { "@type": "MedicalCondition", "name": "Protéine trifonctionnelle mitochondriale", "code": { "@type": "MedicalCode", "code": "D063991", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.765" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sous-unité alpha de la protéine trifonctionnelle mitochondriale", "alternateName": "Mitochondrial Trifunctional Protein, alpha Subunit", "url": "https://questionsmedicales.fr/mesh/D063992", "about": { "@type": "MedicalCondition", "name": "Sous-unité alpha de la protéine trifonctionnelle mitochondriale", "code": { "@type": "MedicalCode", "code": "D063992", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.765.200" } } }, { "@type": "MedicalWebPage", "name": "Sous-unité bêta de la protéine trifonctionnelle mitochondriale", "alternateName": "Mitochondrial Trifunctional Protein, beta Subunit", "url": "https://questionsmedicales.fr/mesh/D063993", "about": { "@type": "MedicalCondition", "name": "Sous-unité bêta de la protéine trifonctionnelle mitochondriale", "code": { "@type": "MedicalCode", "code": "D063993", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.765.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Nucleoside diphosphate kinase D", "alternateName": "Nucleoside Diphosphate Kinase D", "url": "https://questionsmedicales.fr/mesh/D061107", "about": { "@type": "MedicalCondition", "name": "Nucleoside diphosphate kinase D", "code": { "@type": "MedicalCode", "code": "D061107", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.781" } } }, { "@type": "MedicalWebPage", "name": "Peroxiredoxin III", "alternateName": "Peroxiredoxin III", "url": "https://questionsmedicales.fr/mesh/D061105", "about": { "@type": "MedicalCondition", "name": "Peroxiredoxin III", "code": { "@type": "MedicalCode", "code": "D061105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.812" } } }, { "@type": "MedicalWebPage", "name": "Prohibitines", "alternateName": "Prohibitins", "url": "https://questionsmedicales.fr/mesh/D000091402", "about": { "@type": "MedicalCondition", "name": "Prohibitines", "code": { "@type": "MedicalCode", "code": "D000091402", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.844" } } }, { "@type": "MedicalWebPage", "name": "Sirtuine-3", "alternateName": "Sirtuin 3", "url": "https://questionsmedicales.fr/mesh/D056566", "about": { "@type": "MedicalCondition", "name": "Sirtuine-3", "code": { "@type": "MedicalCode", "code": "D056566", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.575.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines mitochondriales", "alternateName": "Mitochondrial Proteins", "code": { "@type": "MedicalCode", "code": "D024101", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Thomas Becker", "url": "https://questionsmedicales.fr/author/Thomas%20Becker", "affiliation": { "@type": "Organization", "name": "Institute of Biochemistry und Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany." } }, { "@type": "Person", "name": "Johannes M Herrmann", "url": "https://questionsmedicales.fr/author/Johannes%20M%20Herrmann", "affiliation": { "@type": "Organization", "name": "Cell Biology, University of Kaiserslautern, Kaiserslautern, Germany. Electronic address: hannes.herrmann@biologie.uni-kl.de." } }, { "@type": "Person", "name": "Timothy E Shutt", "url": "https://questionsmedicales.fr/author/Timothy%20E%20Shutt", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada." } }, { "@type": "Person", "name": "Cole M Haynes", "url": "https://questionsmedicales.fr/author/Cole%20M%20Haynes", "affiliation": { "@type": "Organization", "name": "Molecular, Cell and Cancer Biology, UMass-Chan Medical School, Worcester, MA 01655, USA." } }, { "@type": "Person", "name": "Yang Yang", "url": "https://questionsmedicales.fr/author/Yang%20Yang", "affiliation": { "@type": "Organization", "name": "Stem Cells and Metabolism Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Analysis of home care nurses' workload: A time-motion study.", "datePublished": "2023-04-16", "url": "https://questionsmedicales.fr/article/37061940", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/01621424.2023.2202149" } }, { "@type": "ScholarlyArticle", "name": "The Time, Places, and Activities of Nurses in a Psychiatric Inpatient Context - A Time and Motion Study with a Time-geographic Perspective.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37126738", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/01612840.2023.2194990" } }, { "@type": "ScholarlyArticle", "name": "Activities of the oral health teams in primary health care: a time-motion study.", "datePublished": "2024-05-10", "url": "https://questionsmedicales.fr/article/38730416", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-024-11053-5" } }, { "@type": "ScholarlyArticle", "name": "Understanding the workflow of nurses in acute and subacute medical wards: A time and motion study.", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37489643", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jocn.16835" } }, { "@type": "ScholarlyArticle", "name": "A time motion study of manual versus artificial intelligence methods for wound assessment.", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35901189", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0271742" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines mitochondriales", "item": "https://questionsmedicales.fr/mesh/D024101" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines mitochondriales - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines mitochondriales", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines mitochondriales", "description": "Comment diagnostiquer une dysfonction mitochondriale ?\nQuels tests sanguins sont utilisés pour évaluer les protéines mitochondriales ?\nQuels symptômes indiquent une maladie mitochondriale ?\nLes tests génétiques sont-ils fiables pour les maladies mitochondriales ?\nQuel rôle joue l'imagerie dans le diagnostic mitochondrial ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Time+and+Motion+Studies#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines mitochondriales", "description": "Quels sont les symptômes courants des maladies mitochondriales ?\nLes troubles cognitifs sont-ils liés aux protéines mitochondriales ?\nComment la myopathie mitochondriale se manifeste-t-elle ?\nLes troubles cardiaques sont-ils fréquents dans les maladies mitochondriales ?\nLes symptômes varient-ils selon l'âge d'apparition ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Time+and+Motion+Studies#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines mitochondriales", "description": "Peut-on prévenir les maladies mitochondriales ?\nL'exercice physique peut-il réduire les risques ?\nLes antioxydants jouent-ils un rôle préventif ?\nUne alimentation équilibrée est-elle importante ?\nLes dépistages précoces sont-ils recommandés ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Time+and+Motion+Studies#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines mitochondriales", "description": "Quels traitements sont disponibles pour les maladies mitochondriales ?\nLes coenzymes Q10 sont-elles bénéfiques ?\nLa thérapie génique est-elle une option pour ces maladies ?\nLes régimes alimentaires peuvent-ils aider ?\nLes traitements varient-ils selon le type de maladie mitochondriale ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Time+and+Motion+Studies#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines mitochondriales", "description": "Quelles complications peuvent survenir avec les maladies mitochondriales ?\nLes maladies mitochondriales peuvent-elles affecter la fertilité ?\nLes complications peuvent-elles être gérées ?\nLes maladies mitochondriales augmentent-elles le risque de cancer ?\nLes complications cardiovasculaires sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Time+and+Motion+Studies#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines mitochondriales", "description": "Quels sont les facteurs de risque pour les maladies mitochondriales ?\nL'âge est-il un facteur de risque ?\nLes facteurs environnementaux influencent-ils les maladies mitochondriales ?\nLe stress oxydatif est-il un facteur de risque ?\nLes habitudes alimentaires peuvent-elles influencer le risque ?", "url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=Time+and+Motion+Studies#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction mitochondriale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic peut inclure des tests génétiques, des biopsies musculaires et des analyses biochimiques." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour évaluer les protéines mitochondriales ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de lactate, pyruvate et des enzymes spécifiques peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent une maladie mitochondriale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, faiblesse musculaire, troubles neurologiques et problèmes cardiaques peuvent indiquer une maladie." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils fiables pour les maladies mitochondriales ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier des mutations spécifiques liées aux maladies mitochondriales." } }, { "@type": "Question", "name": "Quel rôle joue l'imagerie dans le diagnostic mitochondrial ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie par résonance magnétique (IRM) peut aider à visualiser des anomalies cérébrales." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des maladies mitochondriales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs musculaires, troubles de la vision et épilepsie." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils liés aux protéines mitochondriales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de dysfonctionnements mitochondriaux." } }, { "@type": "Question", "name": "Comment la myopathie mitochondriale se manifeste-t-elle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une faiblesse musculaire, des crampes et une intolérance à l'exercice." } }, { "@type": "Question", "name": "Les troubles cardiaques sont-ils fréquents dans les maladies mitochondriales ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cardiomyopathies peuvent se développer en raison de dysfonctionnements mitochondriaux." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge d'apparition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier considérablement selon l'âge d'apparition de la maladie." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies mitochondriales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies génétiques ne peuvent pas être prévenues, mais un mode de vie sain aide." } }, { "@type": "Question", "name": "L'exercice physique peut-il réduire les risques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé mitochondriale et réduire les risques." } }, { "@type": "Question", "name": "Les antioxydants jouent-ils un rôle préventif ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antioxydants peuvent protéger les mitochondries des dommages oxydatifs." } }, { "@type": "Question", "name": "Une alimentation équilibrée est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments soutient la santé mitochondriale." } }, { "@type": "Question", "name": "Les dépistages précoces sont-ils recommandés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut aider à identifier les risques et à intervenir rapidement." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les maladies mitochondriales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des suppléments, des thérapies symptomatiques et des approches nutritionnelles." } }, { "@type": "Question", "name": "Les coenzymes Q10 sont-elles bénéfiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le coenzyme Q10 peut améliorer la fonction mitochondriale et réduire les symptômes." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces maladies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais elle pourrait offrir des solutions futures." } }, { "@type": "Question", "name": "Les régimes alimentaires peuvent-ils aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des régimes spécifiques peuvent soutenir la fonction mitochondriale et améliorer les symptômes." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le type de maladie mitochondriale ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements doivent être adaptés au type spécifique de maladie mitochondriale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les maladies mitochondriales ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, cardiaques et endocriniens." } }, { "@type": "Question", "name": "Les maladies mitochondriales peuvent-elles affecter la fertilité ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies mitochondriales peuvent entraîner des problèmes de fertilité." } }, { "@type": "Question", "name": "Les complications peuvent-elles être gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées avec des traitements symptomatiques appropriés." } }, { "@type": "Question", "name": "Les maladies mitochondriales augmentent-elles le risque de cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre dysfonction mitochondriale et risque accru de cancer." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies mitochondriales peuvent entraîner des cardiomyopathies et d'autres complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies mitochondriales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des expositions environnementales." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies mitochondriales se manifestent plus fréquemment avec l'âge." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils les maladies mitochondriales ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut augmenter le risque de dysfonction mitochondriale." } }, { "@type": "Question", "name": "Le stress oxydatif est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut endommager les mitochondries et contribuer à des maladies." } }, { "@type": "Question", "name": "Les habitudes alimentaires peuvent-elles influencer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments peut augmenter le risque de dysfonction mitochondriale." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 07/04/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

25 au total
└─

Aldehyde dehydrogenase, mitochondrial

Aldehyde Dehydrogenase, Mitochondrial D000071396 - D12.776.575.093
└─

Mitochondrial creatine kinase

Creatine Kinase, Mitochondrial Form D052281 - D12.776.575.186
└─

DNA Polymerase gamma

DNA Polymerase gamma D000074002 - D12.776.575.280
└─

Ferrochelatase

Ferrochelatase D005294 - D12.776.575.562
└─

Protéines de transport de la membrane mitochondriale

Mitochondrial Membrane Transport Proteins D033681 - D12.776.575.750
└─

Protéine trifonctionnelle mitochondriale

Mitochondrial Trifunctional Protein D063991 - D12.776.575.765
└─

Nucleoside diphosphate kinase D

Nucleoside Diphosphate Kinase D D061107 - D12.776.575.781
└─

Peroxiredoxin III

Peroxiredoxin III D061105 - D12.776.575.812
└─

Prohibitines

Prohibitins D000091402 - D12.776.575.844
└─

Sirtuine-3

Sirtuin 3 D056566 - D12.776.575.875
└─└─

Mitochondrial ADP, ATP Translocases

Mitochondrial ADP, ATP Translocases D000226 - D12.776.575.750.500
└─└─

Pore de transition de perméabilité mitochondriale

Mitochondrial Permeability Transition Pore D000083162 - D12.776.575.750.563
└─└─

Protéines du complexe d'import des protéines précurseurs mitochondriales

Mitochondrial Precursor Protein Import Complex Proteins D000090622 - D12.776.575.750.594
└─└─

Mitochondrial Proton-Translocating ATPases

Mitochondrial Proton-Translocating ATPases D025261 - D12.776.575.750.625
└─└─

Protéines de découplage mitochondrial

Mitochondrial Uncoupling Proteins D000071245 - D12.776.575.750.688
└─└─

Canal anionique-1 voltage-dépendant

Voltage-Dependent Anion Channel 1 D050995 - D12.776.575.750.750
└─└─

Canal anionique-2 voltage-dépendant

Voltage-Dependent Anion Channel 2 D050996 - D12.776.575.750.875
└─└─

Sous-unité alpha de la protéine trifonctionnelle mitochondriale

Mitochondrial Trifunctional Protein, alpha Subunit D063992 - D12.776.575.765.200
└─└─

Sous-unité bêta de la protéine trifonctionnelle mitochondriale

Mitochondrial Trifunctional Protein, beta Subunit D063993 - D12.776.575.765.500
└─└─└─

Translocateur-1 de nucléotides adényliques

Adenine Nucleotide Translocator 1 D033741 - D12.776.575.750.500.100
└─└─└─

Translocateur-2 de nucléotides adényliques

Adenine Nucleotide Translocator 2 D033742 - D12.776.575.750.500.200
└─└─└─

Translocateur-3 de nucléotides adényliques

Adenine Nucleotide Translocator 3 D033781 - D12.776.575.750.500.300
└─└─└─

Protéine-1 de découplage

Uncoupling Protein 1 D000071256 - D12.776.575.750.688.500
└─└─└─

Protéine-2 de découplage

Uncoupling Protein 2 D000071246 - D12.776.575.750.688.750
└─└─└─

Protéine-3 de découplage

Uncoupling Protein 3 D000071247 - D12.776.575.750.688.875

Auteurs principaux

Thomas Becker

3 publications dans cette catégorie

Affiliations :
  • Institute of Biochemistry und Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
  • CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.
Publications dans "Protéines mitochondriales" :

Johannes M Herrmann

3 publications dans cette catégorie

Affiliations :
  • Cell Biology, University of Kaiserslautern, Kaiserslautern, Germany. Electronic address: hannes.herrmann@biologie.uni-kl.de.
Publications dans "Protéines mitochondriales" :

Timothy E Shutt

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Publications dans "Protéines mitochondriales" :

Cole M Haynes

2 publications dans cette catégorie

Affiliations :
  • Molecular, Cell and Cancer Biology, UMass-Chan Medical School, Worcester, MA 01655, USA.

Yang Yang

2 publications dans cette catégorie

Affiliations :
  • Stem Cells and Metabolism Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
  • School of Life and Health Sciences, Faculty of Science, The Chinese University of Hong Kong, 518172 Shenzhen, China.
Publications dans "Protéines mitochondriales" :

Yury S Bykov

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Publications dans "Protéines mitochondriales" :

Maya Schuldiner

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. Electronic address: maya.schuldiner@weizmann.ac.il.
Publications dans "Protéines mitochondriales" :

Süleyman Bozkurt

2 publications dans cette catégorie

Affiliations :
  • Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.
Publications dans "Protéines mitochondriales" :

Christian Münch

2 publications dans cette catégorie

Affiliations :
  • Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany; Cardio-Pulmonary Institute, Frankfurt am Main, Germany. Electronic address: ch.muench@em.uni-frankfurt.de.
Publications dans "Protéines mitochondriales" :

Bettina Warscheid

2 publications dans cette catégorie

Affiliations :
  • Institute of Biology II, Biochemistry and Functional Proteomics, Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Publications dans "Protéines mitochondriales" :

Sarah Gerlich

2 publications dans cette catégorie

Affiliations :
  • Institute of Molecular Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ Scotland, UK.
  • Department for Chemistry, Institute for Biochemistry, University of Cologne, 50674 Cologne, Germany.
Publications dans "Protéines mitochondriales" :

Markus Räschle

2 publications dans cette catégorie

Affiliations :
  • Molecular Genetics, University of Kaiserslautern, 67663 Kaiserslautern, Germany.
Publications dans "Protéines mitochondriales" :

Nikolaus Pfanner

2 publications dans cette catégorie

Affiliations :
  • Institute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany; CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany. Electronic address: nikolaus.pfanner@biochemie.uni-freiburg.de.
Publications dans "Protéines mitochondriales" :

Nils Wiedemann

2 publications dans cette catégorie

Affiliations :
  • Institute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany; CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany. Electronic address: nils.wiedemann@biochemie.uni-freiburg.de.
Publications dans "Protéines mitochondriales" :

Sahebgowda Sidramagowda Patil

1 publication dans cette catégorie

Affiliations :
  • University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :

Ramani Soundararajan

1 publication dans cette catégorie

Affiliations :
  • University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :

Jutaro Fukumoto

1 publication dans cette catégorie

Affiliations :
  • University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :

Mason Breitzig

1 publication dans cette catégorie

Affiliations :
  • University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
  • Washington University in St. Louis, Brown School, St. Louis, MO, United States.
Publications dans "Protéines mitochondriales" :

Helena Hernández-Cuervo

1 publication dans cette catégorie

Affiliations :
  • University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
  • University of South Florida, Department of Molecular Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :

Matthew Alleyn

1 publication dans cette catégorie

Affiliations :
  • University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :

Sources (10000 au total)

Activities of the oral health teams in primary health care: a time-motion study.

Efficient planning of the oral health workforce in Primary Health Care (PHC) is paramount to ensure equitable community access to services. This requires a meticulous examination of the population's n... Calculate the average time parameters for the activities carried out by the oral health team in primary health care.... This is a descriptive observational study using the time-motion method carried out in five Primary Health Care Units in the city of São Paulo, SP, Brazil. Direct and continuous observation of oral hea... A total of 696.05 h of observation were conducted with 12 Dentists, three Oral Health Assistants, and five Oral Health Technicians. The Dentists' main activity was consultation with an average duratio... The study establishes time standards for the activities performed by the dental care team and provides support for the application of workforce planning methods that allow for review and optimization ...

Understanding the workflow of nurses in acute and subacute medical wards: A time and motion study.

The aim of this study was to determine how much time nurses spend on direct and indirect patient care in acute and subacute hospital settings.... Quantifying direct and indirect nursing care provided during inpatient stay is vital to optimise the quality of care and manage resources.... Time and motion cross-sectional observational study and reported the study according to the STROBE guideline.... Nurses working in an acute or subacute medical wards of a single health service participated. Nurses were observed twice for 2 h on the same day with an observer break in between sessions. Real-time t... Twenty-one nurses (acute n = 12, subacute n = 9) were observed during shifts between 7 AM and 9 PM in May-July 2021. A total of 7240 tasks were recorded. Nurses spent a third of their time on direct p... Time spent on tasks was similar regardless of the setting and was consistent with previous research. We found differences in the distribution of tasks throughout the day between settings, which could ...

A time motion study of manual versus artificial intelligence methods for wound assessment.

This time-motion study explored the amount of time clinicians spent on wound assessments in a real-world environment using wound assessment digital application utilizing Artificial Intelligence (AI) v... Clinicians practicing at Valley Wound Center who agreed to join the study were asked to record the time needed to complete wound assessment activities for patients with active wounds referred for a ro... A total of 91 patients with 115 wounds were assessed. The average time to capture and access wound image with the AI digital tool was significantly faster than a standard digital camera with an averag... Using the digital assessment tool saved significant time for clinicians in assessing wounds. It also successfully captured quality wound images at the first attempt....

Impact of school-based malaria intervention on primary school teachers' time in Malawi: evidence from a time and motion study.

School-based health (SBH) programmes that are contingent on primary school teachers are options to increase access to malaria treatment among learners. However, perceptions that provision of healthcar... A time and motion study was conducted in 10 primary schools in rural Malawi. Teachers who had been trained to diagnose and treat uncomplicated malaria were continuously observed in real time during sc... Seventy-four teachers, trained to use LTK, were observed. Their mean age and years of teaching experience were 34.7 and 8.7, respectively. Overall, 739.8 h of teacher observations took place. The aver... School-based health (SBH) programmes are not detrimental to teaching activities. Teachers manage their time to ensure additional time required for SBH services is not at the expense of teaching duties...

Assessing community health workers' time allocation for a cervical cancer screening and treatment intervention in Malawi: a time and motion study.

Community health workers (CHWs) are essential field-based personnel and increasingly used to deliver priority interventions to achieve universal health coverage. Existing literature allude to the pote... A time and motion study was conducted in 7 health facilities in Malawi. Data was collected at baseline between October-July 2019, and 12 months after CCSPT implementation between July and August 2021.... Thirty-seven (n = 37) CHWs were observed. Their mean age and years of experience were 42 and 17, respectively. Overall, CHWs were observed for 323 hours (inter quartile range: 2.8-5.5). Compared with ... Introduction of CCSPT was not very detrimental to pre-existing community services. CHWs managed their time ensuring additional efforts required for CCSPT were not at the expense of essential activitie...

Determinants of received care time among Finnish home care clients and assisted living facility residents: a time-motion study.

Ageing populations and care workforce shortages across Europe are causing challenges for care services for older people. Therefore, it is paramount that limited care resources are allocated optimally,... Cross-sectional observational study design with data from time and motion study, registers, and surveys was used. In total, 1477 home care clients and 1538 residents from assisted living facilities wi... Physical functioning was the strongest predictor of received care time in both care settings. In home care, greater pain, more unstable health, and higher team autonomy were associated with increased ... Physical functioning was the main driver of received care time. Interventions that maintain or improve physical functioning can help restrain the growing need of care resources, although it is importa...

Time-motion analysis of taekwondo matches in the Tokyo 2020 Olympic Games.

The aim of the present study was to determine the time-motion structure of high-level taekwondo matches during the Tokyo 2020 Olympic Games in relation to sex, match outcome, weight category and match... Overall, 7007 actions were recorded during the analysis of 134 performances (67 rounds of 24 matches: four rounds of 16, eight quarterfinals, eight semifinals and four finals) in male and female flywe... The AT/ST ratio was ~1:1.5. Male athletes performed significantly longer (P<0.001) sum PT than female athletes. Flyweight athletes differed significantly from their heavyweight counterparts by having ... The rule changes and the implementation of the electronic score recording system had a major impact on the time-motion structure of combat by generating a considerably higher AT/ST ratio than in the p...

Electronic oral health surveillance system for Egyptian preschoolers using District Health Information System (DHIS2): design description and time motion study.

Early childhood caries (ECC) is a major global health issue affecting millions of children. Mitigating this problem requires up-to-date information from reliable surveillance systems. This enables evi... The DHIS2 Server was configured for the DHIS2 Tracker Android Capture App to allow individual-level data entry. The EOHSS indicators were selected in line with the WHO Action Plan 2030. Two modalities... The pilot team reported positive feedback on the structure of the EOHSS. Workflow adaptations were made to prioritize surveillance tasks by collecting data from caregivers before acquiring clinical da... The DHIS2 provides a feasible solution for developing electronic, oral health surveillance systems. The one-minute difference in data capture time in telemodality compared to face-to-face indicates th...